Cytokinetics Incorporated has granted stock options to purchase a total of 109,120 shares of common stock and 73,535 restricted stock units (RSUs) to 83 new employees who joined in September and October 2025. The RSUs will vest over three years: 40% on the first anniversary, another 40% on the second anniversary, and the remaining 20% on the third anniversary of the grant date, contingent on continued employment. The stock options, priced at $62.80 per share, will vest over four years with 25% vesting after one year and the remainder vesting in monthly installments over the following three years. The options have a ten-year term.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytokinetics Incorporated published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9547711-en) on October 17, 2025, and is solely responsible for the information contained therein.